(Press-News.org) A duo of scientists at Penn State University has achieved a major milestone in understanding how genomic "dark matter" originates. This "dark matter" -- called non-coding RNA -- does not contain the blueprint for making proteins and yet it comprises more than 95 percent of the human genome. The researchers have discovered that essentially all coding and non-coding RNA originates at the same types of locations along the human genome. The team's findings eventually may help to pinpoint exactly where complex-disease traits reside, since the genetic origins of many diseases reside outside of the coding region of the genome. The research, which will be published as an Advance Online Publication in the journal Nature on 18 September 2013, was performed by B. Franklin Pugh, holder of the Willaman chair in Molecular Biology at Penn State, and postdoctoral scholar Bryan Venters, who now holds a faculty position at Vanderbilt University.
In their research, Pugh and Venters set out to identify the precise location of the beginnings of transcription -- the first step in the expression of genes into proteins. "During transcription, DNA is copied into RNA -- the single-stranded genetic material that is thought to have preceded the appearance of DNA on Earth -- by an enzyme called RNA polymerase and, after several more steps, genes are encoded and proteins eventually are produced," Pugh explained. He added that, in their quest to learn just where transcription begins, other scientists had looked directly at RNA. However, Pugh and Venters instead determined where along human chromosomes the proteins that initiate transcription of the non-coding RNA were located.
"We took this approach because so many RNAs are rapidly destroyed soon after they are made, and this makes them hard to detect," Pugh said. "So rather than look for the RNA product of transcription we looked for the 'initiation machine' that makes the RNA. This machine assembles RNA polymerase, which goes on to make RNA, which goes on to make a protein." Pugh added that he and Venters were stunned to find 160,000 of these "initiation machines," because humans only have about 30,000 genes. "This finding is even more remarkable, given that fewer than 10,000 of these machines actually were found right at the site of genes. Since most genes are turned off in cells, it is understandable why they are typically devoid of the initiation machinery."
The remaining 150,000 initiation machines -- those Pugh and Venters did not find right at genes -- remained somewhat mysterious. "These initiation machines that were not associated with genes were clearly active since they were making RNA and aligned with fragments of RNA discovered by other scientists," Pugh said. "In the early days, these fragments of RNA were generally dismissed as irrelevant since they did not code for proteins." Pugh added that it was easy to dismiss these fragments because they lacked a feature called polyadenylation -- a long string of genetic material, adenosine bases -- that protect the RNA from being destroyed. Pugh and Venters further validated their surprising findings by determining that these non-coding initiation machines recognized the same DNA sequences as the ones at coding genes, indicating that they have a specific origin and that their production is regulated, just like it is at coding genes.
"These non-coding RNAs have been called the 'dark matter' of the genome because, just like the dark matter of the universe, they are massive in terms of coverage -- making up over 95 percent of the human genome. However, they are difficult to detect and no one knows exactly what they all are doing or why they are there," Pugh said. "Now at least we know that they are real, and not just 'noise' or 'junk.' Of course, the next step is to answer the question, 'what, in fact, do they do?'"
Pugh added that the implications of this research could represent one step towards solving the problem of "missing heritability" -- a concept that describes how most traits, including many diseases, cannot be accounted for by individual genes and seem to have their origins in regions of the genome that do not code for proteins. "It is difficult to pin down the source of a disease when the mutation maps to a region of the genome with no known function," Pugh said. "However, if such regions produce RNA then we are one step closer to understanding that disease."
INFORMATION:
The research was funded by the U. S. National Institutes of Health.
CONTACTS
Frank Pugh: 814-863-8252, bfpugh2@gmail.com
Barbara Kennedy (PIO): 814-863-4682, science@psu.edu
ILLUSTRATION
A high-resolution illustration associated with this research is online at http://www.science.psu.edu/news-and-events/2013-news/Pugh9-2013
CAPTIONS AND CREDITS
Image Caption: Shown in the upper left corner of this illustration is a chromosome -- a densely compressed package containing one long, continuous strand of DNA. The DNA is pervasively transcribed into RNA, but only a very small fraction of the RNA has the instructions (or codes) for making proteins. The green circles in this illustration represent places along the strand of DNA where transcription originates. New research led by B. Franklin Pugh of Penn State University shows that essentially all RNA, whether or not it codes for proteins, originates at the same types of locations along the strand of DNA. The findings eventually may help to pinpoint exactly where complex-disease traits reside, since the genetic origins of many diseases reside outside of the coding region of the genome.
Image Credit: National Institutes of Health and B. Franklin Pugh, Penn State University
GRANT NUMBERS
National Institutes of Health (GM059055)
Scientists discover the origins of genomic 'dark matter'
2013-09-19
ELSE PRESS RELEASES FROM THIS DATE:
New sensor could prolong the lifespan of high-temperature engines
2013-09-19
A temperature sensor developed by researchers at the University of Cambridge could improve the efficiency, control and safety of high-temperature engines. The sensor minimises drift –degradation of the sensor which results in faulty temperature readings and reduces the longevity of engine components.
The new sensor, or thermocouple, has been shown to reduce drift by 80 per cent at temperatures of 1200 degrees Celsius, and by 90 per cent at 1300 degrees Celsius, potentially doubling the lifespan of engine components. The results are published in the September issue of ...
Novel gene discovery could lead to new HIV treatments
2013-09-19
A team of researchers led by King's College London has for the first time identified a new gene which may have the ability to prevent HIV, the virus that causes AIDS, from spreading after it enters the body.
Published in Nature today, the study is the first to identify a role for the human MX2 gene in inhibiting HIV. Researchers say this gene could be a new target for effective, less toxic treatments where the body's own natural defence system is mobilised against the virus.
The work was funded by the Medical Research Council and the National Institute for Health ...
Study in New England Journal of Medicine: Colonoscopy saves lives
2013-09-19
Bethesda, MD (Sept. 18, 2013) — A study published in the Sept. 19 New England Journal of Medicine provides some of the clearest evidence to date that colonoscopy has advantages over sigmoidoscopy for the prevention of colorectal cancer.
Researchers followed 88,902 study participants for 22 years and found that 1,815 developed colorectal cancer. Investigators estimated that 40 percent of those cancers could have been prevented if all of the patients in the study had received colonoscopy.
"Thanks to colonoscopy, fewer people than ever before are developing or dying from ...
New treatment for 'arthritis of the spine' prevents paralysis
2013-09-19
Toronto, Canada (September 18, 2013) – In a world-first, decompression surgery has been shown to be an effective procedure to treat cervical spondylotic myelopathy (CSM) – a common progressive, degenerative disease of the spine that can lead to paralysis – according to the results of a multi-centre clinical trial published today.
The study, with its use of multiple outcome measures to determine patient improvement, is the first research of its kind to show that decompression surgery has a significant improvement in both the symptoms and quality of life of CSM patients ...
Study helps deconstruct estrogen's role in memory
2013-09-19
MILWAUKEE – The loss of estrogens at menopause increases a woman's risk of dementia and Alzheimer's disease, yet hormone replacement therapy can cause harmful side effects.
Knowing the exact mechanism of estrogen activation in the brain could lead to new targets for drug development that would provide middle-aged women the cognitive benefits of hormone replacement therapy without increasing their risk for cardiovascular disease or breast cancer.
In a new study, Karyn Frick, professor of psychology at the University of Wisconsin-Milwaukee (UWM), uncovers details about ...
X-ray science taps bug biology to design better materials and reduce pollution
2013-09-19
Bug spray, citronella candles, mosquito netting – most people will do anything they can to stay away from insects during the warmer months. But those creepy crawlers we try so hard to avoid may offer substantial solutions to some of life's problems.
Researchers using the cutting-edge X-ray technology at the U.S. Department of Energy's Advanced Photon Source (APS) were able to take an inside look at several insects, gathering results that go beyond learning about insect physiology and biology. What they found could provide a blueprint for a material used for artificial ...
Beyond quantum simulation: JILA physicists create 'crystal' of spin-swapping ultracold gas molecules
2013-09-19
Physicists at JILA have created a crystal-like arrangement of ultracold gas molecules that can swap quantum "spin" properties with nearby and distant partners. The novel structure might be used to simulate or even invent new materials that derive exotic properties from quantum spin behavior, for electronics or other practical applications.
Described in a Nature paper* posted online on Sept. 18, 2013, the JILA experiment is the first to record ultracold gas molecules exchanging spins at a distance, a behavior that may be similar to that of intriguing solids such as "frustrated" ...
How old memories fade away
2013-09-19
CAMBRIDGE, MA -- If you got beat up by a bully on your walk home from school every day, you would probably become very afraid of the spot where you usually met him. However, if the bully moved out of town, you would gradually cease to fear that area.
Neuroscientists call this phenomenon "memory extinction": Conditioned responses fade away as older memories are replaced with new experiences.
A new study from MIT reveals a gene that is critical to the process of memory extinction. Enhancing the activity of this gene, known as Tet1, might benefit people with posttraumatic ...
Different stories play different roles in patients' health decision-making, MU researcher says
2013-09-19
COLUMBIA, Mo. – Individuals often turn to others for advice when making choices. Perhaps, it seems fitting then, that individuals would seek out others when they are faced with important health decisions. Yet, health communicators have debated whether stories should be included in patient decision-aids (which are informational materials designed to help patients make educated choices about their health) because they worry stories are too biased. Now, an MU researcher has found that stories used in decision-aids don't necessarily bias patients' decision-making; rather, certain ...
Blood biomarker could mark severe cognitive decline, quicker progression among Parkinson's patients
2013-09-19
ROCHESTER, Minn. -- A genetic mutation, known as GBA, that leads to early onset of Parkinson's disease and severe cognitive impairment (in about 4 to 7 percent of all patients with the disease) also alters how specific lipids, ceramides and glucosylceramides are metabolized. Mayo Clinic researchers have found that Parkinson's patients who do not carry the genetic mutation also have higher levels of these lipids in the blood. Further, those who had Parkinson's and high blood levels were also more likely to have cognitive impairment and dementia. The research was recently ...